Michele D. Basso
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Treatment-related deaths with immune checkpoint inhibitor-based combinations versus tyrosine kinase inhibitor monotherapy in hepatocellular carcinoma: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: April 08, 2026
Molecular and Clinical Profile of a RET-Rearranged Colorectal Cancer With Prolonged Response to Platinum Therapy and Subsequent Targeted Treatment With Selpercatinib.
Journal: JCO precision oncology
Published: March 25, 2026
On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.
Journal: Oncology research
Published: February 19, 2026
Complete response to pembrolizumab in a paediatric patient with Lynch syndrome-associated colorectal cancer: a case report and review of immunotherapy-related bowel obstruction.
Journal: Drugs in context
Published: January 27, 2026
Long-term survival and prognostic factors after repeated metastasectomies in metastatic colorectal cancer: a 15-years retrospective study.
Journal: The oncologist
Published: October 14, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.
Journal: Cancers
Published: October 02, 2025
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study).
Journal: Cancer gene therapy
Published: April 03, 2025
Unexplained early deaths in EMERALD-1: is liver failure the reason?
Journal: Lancet (London, England)
Published: March 07, 2025
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.
Journal: Current oncology (Toronto, Ont.)
Published: October 24, 2024
A Retrospective Analysis of Real-Life Management of Colorectal Cancer Lung-Limited Metastases Treated with Surgery: Outcomes and Prognostic Factors.
Journal: Journal of clinical medicine
Published: July 14, 2024
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC).
Journal: Clinical colorectal cancer
Published: June 26, 2024
Last Updated: 09/26/2026